CLGN (CollPlant Biotechnologies) Institutional Ownership: 10.60% (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLGN CollPlant Biotechnologies Ltd CLGN
35 GF Score
Price $0.32
GF Value $0.29
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is CollPlant Biotechnologies Institutional Ownership?

CollPlant Biotechnologies CLGN 35 Institutional Ownership is 10.60% as of Jul. 23, 2026. GuruFocus rates CLGN with a GF Score™ of 35/100 and a GF Value™ of $0.29 (Fairly Valued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CollPlant Biotechnologies's institutional ownership is 10.60%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CollPlant Biotechnologies's Insider Ownership is 3.08%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CollPlant Biotechnologies's Float Percentage Of Total Shares Outstanding is 79.50%.

CollPlant Biotechnologies Institutional Ownership Historical Data

* Premium members only.

The historical data trend for CollPlant Biotechnologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CollPlant Biotechnologies Institutional Ownership Chart

CollPlant Biotechnologies Historical Data

The historical data trend for CollPlant Biotechnologies can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.04
CLGN
35GF Score
CollPlant Biotechnologies Ltd CLGN
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CollPlant Biotechnologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 10.60% mean?
CollPlant Biotechnologies (CLGN) has a Institutional Ownership of 10.60% as of Jul. 23, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on CollPlant Biotechnologies and its competitors.
Is CollPlant Biotechnologies' Institutional Ownership too high?
CollPlant Biotechnologies' current Institutional Ownership is 10.60%. Overall, CollPlant Biotechnologies has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CollPlant Biotechnologies' Institutional Ownership compare to CPMV and TCRT?
CollPlant Biotechnologies' Institutional Ownership of 10.60% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on CollPlant Biotechnologies and its competitors. CollPlant Biotechnologies's current Institutional Ownership is 10.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CollPlant Biotechnologies stock overvalued right now?
Based on GuruFocus' analysis, CollPlant Biotechnologies (CLGN) is currently considered Fairly Valued. The stock's GF Value™ is $0.29, compared to a current price of $0.32 — trading 10.3% above its estimated fair value. The current Institutional Ownership is 10.60%. CollPlant Biotechnologies' overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For CollPlant Biotechnologies (CLGN), the current Institutional Ownership is 10.60% as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CollPlant Biotechnologies (CLGN) Overvalued in 2026?

Based on GuruFocus' analysis, CollPlant Biotechnologies stock appears to be overvalued. The current stock price of $0.32 is trading 10.3% above its estimated GF Value™ of $0.29. GuruFocus considers CollPlant Biotechnologies to be Fairly Valued.

Key valuation signals for CLGN:

  • Institutional Ownership: 10.60%
  • GF Value™: $0.29 vs. price of $0.32 (10.3% above fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the CLGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CollPlant Biotechnologies Business Description

Other Exchanges CPT:Germany
Address 4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
35GF Score

Get the complete analysis for CLGN

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price
$0.29
GF Value